Glioblastoma stem cell metabolism and immunity
Despite enormous efforts being invested in the development of novel therapies for brain malignancies, there remains a dire need for effective treatments, particularly for pediatric glioblastomas. Their poor prognosis has been attributed to the fact that conventional therapies target tumoral cells, b...
Gespeichert in:
| Veröffentlicht in: | Cancer and metastasis reviews 2024-09, Vol.43 (3), p.1015-1035 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1035 |
|---|---|
| container_issue | 3 |
| container_start_page | 1015 |
| container_title | Cancer and metastasis reviews |
| container_volume | 43 |
| creator | Hawly, Joseph Murcar, Micaela G. Schcolnik-Cabrera, Alejandro Issa, Mark E. |
| description | Despite enormous efforts being invested in the development of novel therapies for brain malignancies, there remains a dire need for effective treatments, particularly for pediatric glioblastomas. Their poor prognosis has been attributed to the fact that conventional therapies target tumoral cells, but not glioblastoma stem cells (GSCs). GSCs are characterized by self-renewal, tumorigenicity, poor differentiation, and resistance to therapy. These characteristics represent the fundamental tools needed to recapitulate the tumor and result in a relapse. The mechanisms by which GSCs alter metabolic cues and escape elimination by immune cells are discussed in this article, along with potential strategies to harness effector immune cells against GSCs. As cellular immunotherapy is making significant advances in a variety of cancers, leveraging this underexplored reservoir may result in significant improvements in the treatment options for brain malignancies. |
| doi_str_mv | 10.1007/s10555-024-10183-w |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3003440071</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3088966384</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-a5fbe0294473864b5932a9713770a8f98c268c55f4580a93bb3708af242971e33</originalsourceid><addsrcrecordid>eNp9kD1PwzAQhi0EoqXwBxhQJBYWl7PPjp0RVXxJlVhgtpzUQanipMSJqv57XFJAYmC6wc_73vkh5JLBnAGo28BASkmBC8qAaaTbIzJlUiFVHPGYTIGliqpUZhNyFsIaYghVdkomqCWCFHJK5o911ea1DX3rbRJ655PC1XXiXW_ztq6CT2yzSirvh6bqd-fkpLR1cBeHOSNvD_eviye6fHl8XtwtaYE87amVZe6AZ0Io1KnIZYbcZoqhUmB1memCp7qQshRSg80wz1GBtiUXPFIOcUZuxt5N134MLvTGV2F_mG1cOwSDAChE_A-L6PUfdN0OXROvi5TWWZqiFpHiI1V0bQidK82mq7ztdoaB2ds0o00TbZovm2YbQ1eH6iH3bvUT-dYXARyBEJ-ad9f97v6n9hOSW31E</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3088966384</pqid></control><display><type>article</type><title>Glioblastoma stem cell metabolism and immunity</title><source>SpringerNature Journals</source><creator>Hawly, Joseph ; Murcar, Micaela G. ; Schcolnik-Cabrera, Alejandro ; Issa, Mark E.</creator><creatorcontrib>Hawly, Joseph ; Murcar, Micaela G. ; Schcolnik-Cabrera, Alejandro ; Issa, Mark E.</creatorcontrib><description>Despite enormous efforts being invested in the development of novel therapies for brain malignancies, there remains a dire need for effective treatments, particularly for pediatric glioblastomas. Their poor prognosis has been attributed to the fact that conventional therapies target tumoral cells, but not glioblastoma stem cells (GSCs). GSCs are characterized by self-renewal, tumorigenicity, poor differentiation, and resistance to therapy. These characteristics represent the fundamental tools needed to recapitulate the tumor and result in a relapse. The mechanisms by which GSCs alter metabolic cues and escape elimination by immune cells are discussed in this article, along with potential strategies to harness effector immune cells against GSCs. As cellular immunotherapy is making significant advances in a variety of cancers, leveraging this underexplored reservoir may result in significant improvements in the treatment options for brain malignancies.</description><identifier>ISSN: 0167-7659</identifier><identifier>ISSN: 1573-7233</identifier><identifier>EISSN: 1573-7233</identifier><identifier>DOI: 10.1007/s10555-024-10183-w</identifier><identifier>PMID: 38530545</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Biomedical and Life Sciences ; Biomedicine ; Brain tumors ; Cancer Research ; Cell differentiation ; Cell self-renewal ; Drug resistance ; Effector cells ; Glioblastoma ; Glioma ; Immune response ; Immunotherapy ; Metabolism ; Oncology ; Pediatrics ; Review ; Stem cells ; Targeted cancer therapy ; Tumor microenvironment ; Tumorigenicity</subject><ispartof>Cancer and metastasis reviews, 2024-09, Vol.43 (3), p.1015-1035</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c326t-a5fbe0294473864b5932a9713770a8f98c268c55f4580a93bb3708af242971e33</cites><orcidid>0000-0001-7734-3253 ; 0009-0004-3707-1010 ; 0000-0002-0854-4147 ; 0000-0003-3050-7964</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10555-024-10183-w$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10555-024-10183-w$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38530545$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hawly, Joseph</creatorcontrib><creatorcontrib>Murcar, Micaela G.</creatorcontrib><creatorcontrib>Schcolnik-Cabrera, Alejandro</creatorcontrib><creatorcontrib>Issa, Mark E.</creatorcontrib><title>Glioblastoma stem cell metabolism and immunity</title><title>Cancer and metastasis reviews</title><addtitle>Cancer Metastasis Rev</addtitle><addtitle>Cancer Metastasis Rev</addtitle><description>Despite enormous efforts being invested in the development of novel therapies for brain malignancies, there remains a dire need for effective treatments, particularly for pediatric glioblastomas. Their poor prognosis has been attributed to the fact that conventional therapies target tumoral cells, but not glioblastoma stem cells (GSCs). GSCs are characterized by self-renewal, tumorigenicity, poor differentiation, and resistance to therapy. These characteristics represent the fundamental tools needed to recapitulate the tumor and result in a relapse. The mechanisms by which GSCs alter metabolic cues and escape elimination by immune cells are discussed in this article, along with potential strategies to harness effector immune cells against GSCs. As cellular immunotherapy is making significant advances in a variety of cancers, leveraging this underexplored reservoir may result in significant improvements in the treatment options for brain malignancies.</description><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Brain tumors</subject><subject>Cancer Research</subject><subject>Cell differentiation</subject><subject>Cell self-renewal</subject><subject>Drug resistance</subject><subject>Effector cells</subject><subject>Glioblastoma</subject><subject>Glioma</subject><subject>Immune response</subject><subject>Immunotherapy</subject><subject>Metabolism</subject><subject>Oncology</subject><subject>Pediatrics</subject><subject>Review</subject><subject>Stem cells</subject><subject>Targeted cancer therapy</subject><subject>Tumor microenvironment</subject><subject>Tumorigenicity</subject><issn>0167-7659</issn><issn>1573-7233</issn><issn>1573-7233</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kD1PwzAQhi0EoqXwBxhQJBYWl7PPjp0RVXxJlVhgtpzUQanipMSJqv57XFJAYmC6wc_73vkh5JLBnAGo28BASkmBC8qAaaTbIzJlUiFVHPGYTIGliqpUZhNyFsIaYghVdkomqCWCFHJK5o911ea1DX3rbRJ655PC1XXiXW_ztq6CT2yzSirvh6bqd-fkpLR1cBeHOSNvD_eviye6fHl8XtwtaYE87amVZe6AZ0Io1KnIZYbcZoqhUmB1memCp7qQshRSg80wz1GBtiUXPFIOcUZuxt5N134MLvTGV2F_mG1cOwSDAChE_A-L6PUfdN0OXROvi5TWWZqiFpHiI1V0bQidK82mq7ztdoaB2ds0o00TbZovm2YbQ1eH6iH3bvUT-dYXARyBEJ-ad9f97v6n9hOSW31E</recordid><startdate>20240901</startdate><enddate>20240901</enddate><creator>Hawly, Joseph</creator><creator>Murcar, Micaela G.</creator><creator>Schcolnik-Cabrera, Alejandro</creator><creator>Issa, Mark E.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7734-3253</orcidid><orcidid>https://orcid.org/0009-0004-3707-1010</orcidid><orcidid>https://orcid.org/0000-0002-0854-4147</orcidid><orcidid>https://orcid.org/0000-0003-3050-7964</orcidid></search><sort><creationdate>20240901</creationdate><title>Glioblastoma stem cell metabolism and immunity</title><author>Hawly, Joseph ; Murcar, Micaela G. ; Schcolnik-Cabrera, Alejandro ; Issa, Mark E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-a5fbe0294473864b5932a9713770a8f98c268c55f4580a93bb3708af242971e33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Brain tumors</topic><topic>Cancer Research</topic><topic>Cell differentiation</topic><topic>Cell self-renewal</topic><topic>Drug resistance</topic><topic>Effector cells</topic><topic>Glioblastoma</topic><topic>Glioma</topic><topic>Immune response</topic><topic>Immunotherapy</topic><topic>Metabolism</topic><topic>Oncology</topic><topic>Pediatrics</topic><topic>Review</topic><topic>Stem cells</topic><topic>Targeted cancer therapy</topic><topic>Tumor microenvironment</topic><topic>Tumorigenicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hawly, Joseph</creatorcontrib><creatorcontrib>Murcar, Micaela G.</creatorcontrib><creatorcontrib>Schcolnik-Cabrera, Alejandro</creatorcontrib><creatorcontrib>Issa, Mark E.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer and metastasis reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hawly, Joseph</au><au>Murcar, Micaela G.</au><au>Schcolnik-Cabrera, Alejandro</au><au>Issa, Mark E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glioblastoma stem cell metabolism and immunity</atitle><jtitle>Cancer and metastasis reviews</jtitle><stitle>Cancer Metastasis Rev</stitle><addtitle>Cancer Metastasis Rev</addtitle><date>2024-09-01</date><risdate>2024</risdate><volume>43</volume><issue>3</issue><spage>1015</spage><epage>1035</epage><pages>1015-1035</pages><issn>0167-7659</issn><issn>1573-7233</issn><eissn>1573-7233</eissn><abstract>Despite enormous efforts being invested in the development of novel therapies for brain malignancies, there remains a dire need for effective treatments, particularly for pediatric glioblastomas. Their poor prognosis has been attributed to the fact that conventional therapies target tumoral cells, but not glioblastoma stem cells (GSCs). GSCs are characterized by self-renewal, tumorigenicity, poor differentiation, and resistance to therapy. These characteristics represent the fundamental tools needed to recapitulate the tumor and result in a relapse. The mechanisms by which GSCs alter metabolic cues and escape elimination by immune cells are discussed in this article, along with potential strategies to harness effector immune cells against GSCs. As cellular immunotherapy is making significant advances in a variety of cancers, leveraging this underexplored reservoir may result in significant improvements in the treatment options for brain malignancies.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>38530545</pmid><doi>10.1007/s10555-024-10183-w</doi><tpages>21</tpages><orcidid>https://orcid.org/0000-0001-7734-3253</orcidid><orcidid>https://orcid.org/0009-0004-3707-1010</orcidid><orcidid>https://orcid.org/0000-0002-0854-4147</orcidid><orcidid>https://orcid.org/0000-0003-3050-7964</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0167-7659 |
| ispartof | Cancer and metastasis reviews, 2024-09, Vol.43 (3), p.1015-1035 |
| issn | 0167-7659 1573-7233 1573-7233 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3003440071 |
| source | SpringerNature Journals |
| subjects | Biomedical and Life Sciences Biomedicine Brain tumors Cancer Research Cell differentiation Cell self-renewal Drug resistance Effector cells Glioblastoma Glioma Immune response Immunotherapy Metabolism Oncology Pediatrics Review Stem cells Targeted cancer therapy Tumor microenvironment Tumorigenicity |
| title | Glioblastoma stem cell metabolism and immunity |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T04%3A48%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glioblastoma%20stem%20cell%20metabolism%20and%20immunity&rft.jtitle=Cancer%20and%20metastasis%20reviews&rft.au=Hawly,%20Joseph&rft.date=2024-09-01&rft.volume=43&rft.issue=3&rft.spage=1015&rft.epage=1035&rft.pages=1015-1035&rft.issn=0167-7659&rft.eissn=1573-7233&rft_id=info:doi/10.1007/s10555-024-10183-w&rft_dat=%3Cproquest_cross%3E3088966384%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3088966384&rft_id=info:pmid/38530545&rfr_iscdi=true |